EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A peripheral blood-based approach involving vimentin along with AURKA enabled efficient tracking of elusive Oct4/Sox2-expressing disseminated breast cancer stem cells

Debomita Sengupta iD, Debanjan Thakur iD, Elizabeth Mahapatra iD, Salini Das iD, Jayanta Chakrabarti, Sagar Sen iD, Sutapa Mukherjee iD

Bioscience Reports · 22.07.2026 · 46 (7)

DOI: 10.1042/bsr20253828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 24.06.2026. Verfasst von Debomita Sengupta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Carcinogenesis and Toxicology, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India. Hauptthemen laut MEDLINE: Aurora Kinase A, Octamer Transcription Factor-3, SOXB1 Transcription Factors, Neoplastic Stem Cells. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major impediment in the therapeutic success of breast cancer (BC) arises from the persistence of clinically undetectable breast cancer stem cells (BCSCs) that need addressal by targeting translationally relevant markers to restrain relapse. Aurora kinase A (AURKA), due to its negative prognostic effect, was considered in clinical trials yet showed an unappreciable response, highlighting the need for additional markers. The present study tried exploring AURKA as a tool of relevance to detect the abundance of Oct4/Sox2(octamer-binding transcription factor 4/sex-determining region Y-box 2)-expressing BCSCs. The purpose was to understand the underlying intricacies governing the limited success of AURKA inhibition and to seek an improved relevant marker profile for detecting disseminated BCSCs. Flow cytometry and chromatin immunoprecipitation assay findings correlated Oct4/Sox2/AURKA expression, proposing an Oct4/Sox2 threshold-dependent AURKA induction. Surprisingly, in BC patient blood, Oct4/Sox2+ve cells were apparently lacking AURKA, emphasizing marker profile dynamicity in disseminating BCSCs with transient cell fate alterations. Immunoprecipitation/immunofluorescence results highlighted an interaction of pAURKA with fate-determinant pNUMB, hinting toward the existence of an AURKA/pNUMB axis for mesenchymal fate induction in breast cancer cells. Oct4/Sox2/AURKA+ve cells further expressed vimentin, highlighting a mesenchymal fate in BCSCs as evident from correlated Oct4/Sox2 and vimentin expression in patient blood. Hence, our study indicated an existing Oct4/Sox2/AURKA/pNUMB axis during transient mesenchymal differentiation of BCSCs and subsequently advocated for a peripheral blood-based approach using AURKA and vimentin for tracking BCSCs, thus supporting a co-targeting strategy. Preliminary in vitro intervention using combinatorial targeting of AURKA and vimentin reduced stemness propensities. Based on these interesting observations, further in-depth studies are warranted for clinical validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aurora Kinase AOctamer Transcription Factor-3SOXB1 Transcription FactorsNeoplastic Stem CellsBreast NeoplasmsVimentinBiomarkers, TumorHumansFemaleCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AURKAAtorvastatinBreast cancer stem cellsOct4Sox2Vimentin

Substanzen

Aurora Kinase AOctamer Transcription Factor-3SOXB1 Transcription FactorsPOU5F1 protein, humanSOX2 protein, humanAURKA protein, humanVimentinBiomarkers, TumorVIM protein, human

Autor:innen und Institutionen

  • Department of Environmental Carcinogenesis and Toxicology, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India.
  • Department of Neurosurgery, The Houston Methodist Research Institute, Houston, Texas, U.S.A.
  • Director & HoD, Department of Surgical Oncology, Chittaranjan National Cancer Institute, Hazra Campus: 37, S. P. Mukherjee Road, Kolkata-700 026, INDIA, Newtown Campus: Street No. 299, DJ Block, Action Area 1D, Kolkata…
  • Department of Surgical Oncology, Chittaranjan National Cancer Institute, Street No. 299, DJ Block, Action Area 1D, Kolkata - 700160, INDIA.

ORCID-Profile: Debomita Sengupta, Debanjan Thakur, Elizabeth Mahapatra, Salini Das, Sagar Sen, Sutapa Mukherjee

Zitieren

APA

Sengupta, D., Thakur, D., Mahapatra, E., Das, S., Chakrabarti, J., Sen, S., & Mukherjee, S. (2026). A peripheral blood-based approach involving vimentin along with AURKA enabled efficient tracking of elusive Oct4/Sox2-expressing disseminated breast cancer stem cells. Bioscience Reports, 46(7). https://doi.org/10.1042/bsr20253828

Vancouver

Sengupta D, Thakur D, Mahapatra E, Das S, Chakrabarti J, Sen S, et al. A peripheral blood-based approach involving vimentin along with AURKA enabled efficient tracking of elusive Oct4/Sox2-expressing disseminated breast cancer stem cells. Bioscience Reports. 2026;46(7). doi:10.1042/bsr20253828

BibTeX
@article{Sengupta2026,
  author = {Sengupta, Debomita and Thakur, Debanjan and Mahapatra, Elizabeth and Das, Salini and Chakrabarti, Jayanta and Sen, Sagar and Mukherjee, Sutapa},
  title = {A peripheral blood-based approach involving vimentin along with AURKA enabled efficient tracking of elusive Oct4/Sox2-expressing disseminated breast cancer stem cells},
  journal = {Bioscience Reports},
  year = {2026},
  volume = {46},
  number = {7},
  doi = {10.1042/bsr20253828}
}
Kostenlos starten →